A UT Southwestern Medical Center quality improvement team led a large-scale, multispecialty project in partnership with the Parkland Center of Innovation and Value to help patients with implantable ...

The new device created by researchers at Georgia Tech and Emory hopes to change the treatment of heart valve disease forever.

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...

Patients at Baylor Medicine, the primary multidisciplinary clinical practice of Baylor College of Medicine, and Baylor St.

Using a small catheter inserted in the leg, the TriClip is delivered to the heart and works by clipping together a portion of the leaflets of the tricuspid valve.

A new study, published today in The Lancet Respiratory Medicine, has tested whether a set of interventions to keep lungs ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk ...

One in five older adults gets an infection up to six months after heart surgery, and women are far more likely to develop one, according to recent studies. Black patients also had higher rates of ...